Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1Osteoporosis 1Neoplasms 1Neoplasm Metastasis 1Genetic Diseases, Inborn 1Breast Neoplasms 1

Interventions

thymoglobulin 1ixazomib 1Transplantation 1Ketoconazole 1Cord Blood Stem Cell Transplantation 1Clinical Trials, Phase II as Topic 1Circulating Tumor DNA 1Antilymphocyte Serum 1Alendronate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Genetic Diseases, Inborn × Alendronate × Clear all
NCT00019695 2024-03-04

Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer

National Cancer Institute (NCI)

Phase 2 Terminated
Genitourinary

Neoplasm Metastasis, Neoplasms, Prostatic Neoplasms, Genetic Diseases, Inborn

Data powered by HemOnc (CC BY 4.0) Colophon âš¡